v3.26.1
Summary of Significant Accounting Policies (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Mar. 31, 2022
Summary of Significant Accounting Policies [Line Items]      
Other income $ 3,556  
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Chief Executive Officer [Member]    
CODM, description The CODM assesses performance and allocates resources based on the Company’s consolidated statements of operations, and key components and processes of the Company’s operations are managed centrally. Segment asset information is not used by the CODM to allocate resources. The Chief Executive Officer uses operating losses and cash flows from operating activities to evaluate performance of the operating segment assets in deciding how to allocate the cash resources. Significant expenses presented to the CODM include research and development and general and administrative expenses, which are each separately presented on the Company’s consolidated statements of operations.    
Allowance for doubtful accounts  
Impairment charges  
Recognized income tax percentage 50.00%    
Uncertain tax positions  
Contingent earnout provisions    
Patents [Member]      
Summary of Significant Accounting Policies [Line Items]      
Estimated useful life 20 years    
Mabwell (Shanghai) Bioscience Co., Ltd. [Member]      
Summary of Significant Accounting Policies [Line Items]      
Receivables     $ 3,500
Other income   $ 3,500  
Contingent Earnout Shares [Member]      
Summary of Significant Accounting Policies [Line Items]      
Additional shares (in Shares) 483,334    
AbMed [Member]      
Summary of Significant Accounting Policies [Line Items]      
Ownership interest 82.00%    
Preferred Share [Member]      
Summary of Significant Accounting Policies [Line Items]      
Redemption price per share (in Dollars per share) $ 2